Literature DB >> 12829415

The adrenochrome hypothesis of schizophrenia revisited.

John Smythies1.   

Abstract

This paper reviews the current status of the adrenochrome theory of schizophrenia. An account is first given of all the experiments in which adrenochrome was reported to induce psychotomimetic effects in normal volunteers. Then the evidence is presented that adrenochrome may actually occur in the brain as a metabolite of adrenaline in the C2 group of adrenergic neurons in the medulla, together with an account of current ideas of the function of these neurons in higher limbic functions. Lastly the recent evidence is reviewed that the gene for the enzyme glutathione S-transferase is defective in schizophrenia. This enzyme detoxifies adrenochrome.

Entities:  

Year:  2002        PMID: 12829415     DOI: 10.1080/10298420290015827

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  24 in total

1.  Schizophrenia; a new approach. II. Result of a year's research.

Authors:  A HOFFER; H OSMOND; J SMYTHIES
Journal:  J Ment Sci       Date:  1954-01

2.  Schizophrenia: a new approach.

Authors:  H OSMOND; J SMYTHIES
Journal:  J Ment Sci       Date:  1952-04

Review 3.  The oxidative metabolism of catecholamines in the brain: a review.

Authors:  J Smythies; L Galzigna
Journal:  Biochim Biophys Acta       Date:  1998-04-10

4.  Adrenergic innervation of the monkey thalamus: an immunohistochemical study.

Authors:  B Rico; C Cavada
Journal:  Neuroscience       Date:  1998-06       Impact factor: 3.590

5.  Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry.

Authors:  J R Smythies; R D Morin; G B Brown
Journal:  Biol Psychiatry       Date:  1979-06       Impact factor: 13.382

6.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

7.  Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease.

Authors:  W P Gai; L B Geffen; L Denoroy; W W Blessing
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

8.  Organization of medullary adrenergic and noradrenergic projections to the periaqueductal gray matter in the rat.

Authors:  H Herbert; C B Saper
Journal:  J Comp Neurol       Date:  1992-01-01       Impact factor: 3.215

9.  Adrenergic innervation of forebrain neurons that project to the paraventricular thalamic nucleus in the rat.

Authors:  K Otake; D A Ruggiero; Y Nakamura
Journal:  Brain Res       Date:  1995-10-30       Impact factor: 3.252

Review 10.  On the functional of neuromelanin.

Authors:  J Smythies
Journal:  Proc Biol Sci       Date:  1996-04-22       Impact factor: 5.349

View more
  4 in total

1.  Neurotoxicological and neuroprotective elements in Parkinson's disease.

Authors:  Richard M. Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

2.  Dopamine thioethers: formation in brain and neurotoxicity.

Authors:  Kathleen S. Montine; Kathrin R. Sidell; Jing Zhang; Thomas J. Montine
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 3.  Reviewing the ketamine model for schizophrenia.

Authors:  Joel Frohlich; John D Van Horn
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

4.  Studies on enzymatic oxidation of 3',4'-dihydroxy-l-phenylalanine to dopachrome using kinetic isotope effect methods.

Authors:  Wioleta Byszewska; Marianna Kańska
Journal:  J Radioanal Nucl Chem       Date:  2013-12-10       Impact factor: 1.371

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.